Last updated on February 2019
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Brief description of study
The purpose of this study is to evaluate the effect of LCZ696 compared to valsartan on cognitive function in patients with chronic heart failure and preserved ejection fraction. Cognitive function will be assessed using a comprehensive battery of tests with an evaluation of longitudinal change of cognitive domains including memory, executive function, and attention.
Clinical Study Identifier: NCT02884206
Start Over
Novartis Pharmaceuticals
Novartis Investigative Site South Miami, FL United States0.48miles
Connect »